Medical Science 2022 Paper I 50 marks Discuss

Q3

(a) (i) Discuss the functions of basal ganglia. Add a note on Parkinson's disease. (5+5=10 marks) (ii) Discuss the mechanism of excitation-contraction coupling in the skeletal muscle. (10 marks) (b) Explain the biochemical role of the different derivatives of vitamin A. Add a note on the causes, clinical manifestations and management of vitamin A deficiency. (15 marks) (c) (i) Describe the functional components, course, branches and applied aspects of the facial nerve. (10 marks) (ii) Discuss the attachments and applied aspects of rotator cuff muscles of the shoulder joint. (5 marks)

हिंदी में प्रश्न पढ़ें

(a) (i) आधारी गांडिका के कार्यों की व्याख्या कीजिए। साथ ही पार्किनसन रोग पर एक टिप्पणी लिखिए। (5+5=10) (ii) कंकाल पेशी में उत्तेजन-संकुचन युग्मन की क्रियाविधि की व्याख्या कीजिए। (10) (b) विटामिन A के विभिन्न व्युत्पन्नों की जैव रासायनिक भूमिका की व्याख्या कीजिए। साथ ही विटामिन A अल्पता के कारणों, रोगलक्षण अभिव्यक्तियों तथा प्रबंधन पर एक टिप्पणी लिखिए। (15) (c) (i) आनन तंत्रिका के क्रियात्मक घटकों, मार्ग, शाखाओं तथा अनुप्रयुक्त पहलुओं का वर्णन कीजिए। (10) (ii) स्कंध संधि की रोटर कफ पेशियों के संलग्नकों तथा अनुप्रयुक्त पहलुओं की व्याख्या कीजिए। (5)

Evaluate your answer to this question → See all 2022 Medical Science questions

Directive word: Discuss

This question asks you to discuss. The directive word signals the depth of analysis expected, the structure of your answer, and the weight of evidence you must bring.

See our UPSC directive words guide for a full breakdown of how to respond to each command word.

How this answer will be evaluated

Approach

The directive 'discuss' demands a comprehensive, analytical treatment with balanced coverage across all four sub-parts. Allocate approximately 20% (10 marks) to (a)(i) basal ganglia and Parkinson's, 20% (10 marks) to (a)(ii) excitation-contraction coupling, 30% (15 marks) to (b) vitamin A biochemistry and deficiency, and 30% (15 marks) to (c)(i) facial nerve and (c)(ii) rotator cuff combined. Structure with brief introductions for each sub-part, detailed mechanistic explanations in the body, and applied/clinical conclusions. For (a)(ii) and facial nerve, prioritize labeled diagrams.

Key points expected

  • Basal ganglia: motor control loops (direct/indirect pathways), role in movement initiation and inhibition; Parkinson's: dopaminergic neuron loss in substantia nigra pars compacta, Lewy bodies, TRAP symptoms
  • Excitation-contraction coupling: T-tubule depolarization, DHP receptors, RyR1 calcium release, calcium-troponin C binding, cross-bridge cycling, SERCA-mediated relaxation
  • Vitamin A derivatives: retinal (vision/rhodopsin), retinoic acid (gene transcription/RAR/RXR), retinol (transport/storage); deficiency causes: dietary (India's ICDS program relevance), malabsorption, liver disease; manifestations: night blindness, Bitot's spots, xerophthalmia, keratomalacia; management: oral retinol, IM in malabsorption, prevention through VAS program
  • Facial nerve: functional components (SVE, SVA, GVE, GSA), course through internal acoustic meatus, facial canal, stylomastoid foramen; branches: greater petrosal, chorda tympani, posterior auricular, temporal/zygomatic/buccal/mandibular/cervical; applied: Bell's palsy, House-Brackmann grading, corneal protection
  • Rotator cuff: SITS muscles (supraspinatus, infraspinatus, teres minor, subscapularis) attachments to greater/lesser tubercles; applied: impingement syndrome, painful arc, tears in repetitive overhead workers

Evaluation rubric

DimensionWeightMax marksExcellentAveragePoor
Concept correctness25%12.5Precise neuroanatomical terminology for basal ganglia pathways (direct: D1, indirect: D2 receptors); accurate molecular details of ECC including DHP-RyR1 coupling; correct biochemical pathways of retinol metabolism and RAR/RXR function; exact facial nerve branch distributions and rotator cuff insertionsGeneral description of basal ganglia functions without pathway specifics; basic ECC sequence without molecular details; lists vitamin A forms without biochemical mechanisms; describes facial nerve course but confuses branch distributions; knows SITS muscles without precise attachmentsConfuses basal ganglia with cerebellum; omits calcium's role in ECC; conflates vitamin A with vitamin D; misidentifies facial nerve branches or omits functional components; cannot name all four rotator cuff muscles
Clinical correlation20%10Integrates TRAP symptoms with basal ganglia pathology; links ECC failure to malignant hyperthermia/ryanodine receptor mutations; connects vitamin A deficiency to India's VAS program and WHO classification of xerophthalmia; applies House-Brackmann grading to facial nerve lesions; correlates rotator cuff pathology with occupational groupsLists Parkinson's symptoms without pathophysiological link; mentions malignant hyperthermia without mechanism; describes night blindness without staging; states Bell's palsy without grading; mentions painful arc without anatomical basisClinical features mentioned without disease names; no connection between basic science and clinical presentation; omits all applied aspects despite question requirement
Diagram / pathway20%10Labeled diagram of basal ganglia circuitry showing cortex-striatum-GPi/SNr-thalamus-cortex loop; detailed ECC diagram with T-tubule, SR, triad, and molecular components; facial nerve schematic showing course and all branches; rotator cuff muscle diagram with humeral insertions; vitamin A metabolic pathway with tissue-specific conversionsBasic basal ganglia structure without circuitry; simple muscle fiber diagram without molecular labels; lists facial nerve branches without anatomical course; names rotator cuff muscles without diagram; describes vitamin A forms without metabolic interconversionNo diagrams despite clear pictorial demands; text-only descriptions where visual representation is essential; incorrect anatomical relationships in any attempted diagrams
Differential / staging15%7.5Differentiates Parkinson's from parkinsonism plus syndromes (MSA, PSP, MPTP-induced); distinguishes vitamin A deficiency stages (XN, XN1, XA, XF, XS, XO per WHO); differentiates Bell's palsy from Ramsay Hunt, acoustic neuroma, UMN lesions; grades rotator cuff tears (partial vs full-thickness, Sugaya classification)Mentions Parkinson's vs essential tremor without details; knows night blindness progresses to blindness without WHO staging; distinguishes upper vs lower motor neuron facial palsy; describes impingement vs tear without classificationNo differential diagnoses offered; no staging systems mentioned despite clear applicability; confuses similar conditions (e.g., Parkinson's with Huntington's)
Management / public-health angle20%10Levodopa/carbidopa, dopamine agonists, MAO-B inhibitors for Parkinson's with deep brain stimulation indications; vitamin A deficiency management per WHO protocol (200,000 IU oral/IM), India's National Vitamin A Prophylaxis Program, ICDS integration; facial palsy: corticosteroids, eye protection, surgical decompression criteria; rotator cuff: conservative (physiotherapy) vs surgical (arthroscopic repair) indicationsLists Parkinson's drugs without mechanism or staging; mentions vitamin A supplementation without dosing; describes eye patching for facial palsy; mentions physiotherapy for rotator cuff without specific protocolsNo management details despite explicit question requirement; vague statements like 'treat with medicine'; omits public health relevance of vitamin A deficiency in Indian context

Practice this exact question

Write your answer, then get a detailed evaluation from our AI trained on UPSC's answer-writing standards. Free first evaluation — no signup needed to start.

Evaluate my answer →

More from Medical Science 2022 Paper I